Skip to main content

Table 3 Genes and genomes pathway analysis of miR-146a target genes

From: Genome–wide microRNA expression profiling in placentas from pregnant women exposed to BPA

Pathway

Gene Symbol

Gene Name

Apoptosis

IRAK1

interleukin-1 receptor-associated kinase 1,

Cancer

APPL1

adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1;

SLC22A3

solute carrier family 22 (extraneuronal monoamine transporter), member 3;

ERBB4

v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian);

NOTCH1

notch 1;

SMAD4

SMAD family member 4;

CSF1R

colony stimulating factor 1 receptor;

DOT1L

DOT1-like, histone H3 methyltransferase (S. cerevisiae);

PTGFRN

prostaglandin F2 receptor negative regulator;

IGF2BP1

insulin-like growth factor 2 mRNA binding protein 1;

BCL11A

B-cell CLL/lymphoma 11A (zinc finger protein);

RAD1

RAD1 homolog (S. pombe);

HIC2

hypermethylated in cancer 2;

MLL2

myeloid/lymphoid or mixed-lineage leukemia 2;

EDNRB

endothelin receptor type B;

NOVA1

neuro-oncological ventral antigen 1;

ABL2

v-abl Abelson murine leukemia viral oncogene homolog 2

Mapk pathway

TRAF6

TNF receptor-associated factor 6

Cell differentation

NOTCH1

notch 1;

SRP14

signal recognition particle 14 kDa (homologous Alu RNA binding protein);

PSMD3

proteasome (prosome, macropain) 26S subunit, non-ATPase, 3;

GDNF

glial cell derived neurotrophic factor;

SMAD4

SMAD family member 4;

SEMA3G

sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G;

MED1

mediator complex subunit 1;

LIPA

lipase A, lysosomal acid, cholesterol esterase;

ROBO1

roundabout, axon guidance receptor, homolog 1 (Drosophila);

Metabolic pathway

SLC22A3

solute carrier family 22 (extraneuronal monoamine transporter), member 3;

PGP

phosphoglycolate phosphatase;

LIPA

lipase A, lysosomal acid, cholesterol esterase;

DLST

dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex);

DOT1L

DOT1-like, histone H3 methyltransferase (S. cerevisiae);

BCL11A

B-cell CLL/lymphoma 11A (zinc finger protein;

DGKG

diacylglycerol kinase, gamma 90 kDa;

Neural disease

IRAK1

interleukin-1 receptor-associated kinase 1;

MYT1

myelin transcription factor 1;

ROBO1

roundabout, axon guidance receptor, homolog 1 (Drosophila);

LRRTM2

leucine rich repeat transmembrane neuronal 2;

GRID1

glutamate receptor, ionotropic, delta 1;

SORT1

sortilin 1;

BCL11A

B-cell CLL/lymphoma 11A (zinc finger protein);

SYT1

synaptotagmin I;

NPAS4

neuronal PAS domain protein 4;

MLL2

myeloid/lymphoid or mixed-lineage leukemia 2;

DNAL1

dynein, axonemal, light chain 1;

EDNRB

endothelin receptor type B;

Binding protein

NOVA1

neuro-oncological ventral antigen 1;

HNRNPD

heterogeneous nuclear ribonucleoprotein D

Signal trasduction

ABL2

v-abl Abelson murine leukemia viral oncogene homolog 2;

NUMB

numb homolog (Drosophila);

CNTFR

ciliary neurotrophic factor receptor;

SRP14

signal recognition particle 14 kDa (homologous Alu RNA binding protein);

GDNF

glial cell derived neurotrophic factor;

SMAD4

SMAD family member 4;

KCTD15

potassium channel tetramerisation domain containing 15;

NF2

neurofibromin 2 (merlin);

KLF4

Kruppel-like factor 4 (gut);

SCN3B

sodium channel, voltage-gated, type III, beta;

NLGN1

neuroligin 1;

RIMS2

regulating synaptic membrane exocytosis 2;

Cardiovascular disease

ABL2

v-abl Abelson murine leukemia viral oncogene homolog 2;

EIF4G2

eukaryotic translation initiation factor 4 gamma, 2;

EDNRB

endothelin receptor type B;

Ubiquitin pathway

DCAF12

DDB1 and CUL4 associated factor 12;

FBXW2

F-box and WD repeat domain containing 2;

WWP2

WW domain containing E3 ubiquitin protein ligase 2;

DTL

denticleless homolog (Drosophila);

Trasport protein

SLC10A3

solute carrier family 10 (sodium/bile acid cotransporter family), member 3;

ERBB4

v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian);

EIF4G2

eukaryotic translation initiation factor 4 gamma, 2;

SH3GL2

SH3-domain GRB2-like 2;

SLCO3A1

solute carrier organic anion transporter family, member 3A1;

GOSR1

golgi SNAP receptor complex member 1;

SLC39A1

solute carrier family 39 (zinc transporter), member 1;

SORT1

sortilin 1;

BTG2

BTG family, member 2;

Enzyme

ERBB4

v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian);

ADARB1

adenosine deaminase, RNA-specific, B1;

USP3

ubiquitin specific peptidase 3;

KDM2B

lysine (K)-specific demethylase 2B;

SIAH2

seven in absentia homolog 2 (Drosophila);

CASK

calcium/calmodulin-dependent serine protein kinase (MAGUK family);

LIPA

lipase A, lysosomal acid, cholesterol esterase;

CNOT6L

TRDMT1

CCR4-NOT transcription complex, subunit 6-like;

MPPE1

tRNA aspartic acid methyltransferase 1;

DCP1A

DCP1 decapping enzyme homolog A (S. cerevisiae);

DLGAP2

discs, large (Drosophila) homolog-associated protein 2;

Kinase protein associated

TRAF6

TNF receptor-associated factor 6;

PCDH1

protocadherin 1;

Prion disease

NOTCH1

notch 1

Infection disease

APPL1

adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1;

PGP

phosphoglycolate phosphatase;

PSMD3

proteasome (prosome, macropain) 26S subunit, non-ATPase, 3;

SMAD4

SMAD family member 4;

TAF9B

TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31 kDa;

CD28

CD28 molecule;

WASF2

WAS protein family, member 2;

SRSF7

serine/arginine-rich splicing factor 7;

Trascriptor factor

MAFF

v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian);

CSF1R

colony stimulating factor 1 receptor;

TAF9B

TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor;

EIF5A2

eukaryotic translation initiation factor 5A2;

KLF4

Kruppel-like factor 4 (gut);

SP8

Sp8 transcription factor;

SOX5

SRY (sex determining region Y)-box 5;

Endocrine system

MED1

mediator complex subunit 1;

TP53RK

TP53 regulating kinase;

Cellular antigen

CD84

CD84 molecule

Mirna survelliance

PPP2R3A

protein phosphatase 2, regulatory subunit B’, alpha;

RIMS2

regulating synaptic membrane exocytosis 2;